Mangaluru: Two years on, MBBS student Rohit's death still a mystery

Mandya, Jul 23: Upset over contracting Covid 19, a 55-year-old man, ended his life by hanging himself, at the designated Covid hospital, in Mandya, on Wednesday night.

The deceased patient is from Kandegala village, Malvalli taluk, Mandya district. He was ailing from renal problems and was under treatment. 

However, he contracted the virus and tested positive for Covid-19. Upset over this, he ended his life by hanging himself on the window grill, in the hospital bathroom, midnight. The incident came to light when other patients went to the toilet.

His last rites were conducted as per the designated Covid-19 protocol, on Thursday, said District Health Officer Dr H P Manchegowda.

Mangaluru, Jan 29: The Indian Coast Guard today commissioned a high-speed coast interceptor boat at New Mangalore Port here giving a fillip to the coastal security.

The water jet propelled Interceptor Boat C-448 (27.80 mts in length) has an endurance of 500 nautical miles at 20 knots.

The vessel fitted with latest state of the art navigation and communication equipment can achieve a speed of 45 knots. Thus, the vessel is designed for high speed interception, close coast patrol, low intensity maritime operations, maritime surveillance, search and rescue.

The quick reaction capability coupled with modern equipment and system ensures that the vessel responds to any maritime situation. With a crew of 12 personnel, C-448 is Commanded by Assistant Commandant Apoorva Sharma.

The Interceptor Boat will be based at Mangaluru. T. M. Vijaya Bhasker, Chief Secretary Karnataka, who commissioned the IB, said that the crew should discharge their duties faithfully and with courage. Anand Prakash Badola, Commander, Coast Guard Region ( West) and A.V. Ramana, Chairman, New Mangalore Port Trust, were present on the occasion.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.